Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Benzothiazinone derivative, preparation method thereof and application of benzothiazinone derivative as antituberculosis drug

A technology of benzothiazinone and derivatives is applied in the fields of benzothiazinone derivatives and their preparation and application as anti-tuberculosis drugs, can solve problems such as poor drugability and the like, and achieves low cLogP value, good drugability, The effect of excellent inhibitory effect

Inactive Publication Date: 2020-06-19
SUZHOU UNIV
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004]Anti-tuberculosis drugs targeting DprE1 with benzothiazinone (BTZ) as the backbone, currently under development are BTZ043 (phase I) and pBTZ169 (phase II ), the MICs of the two compounds against the standard strain of Mycobacterium tuberculosis were 0.02 μM and 0.004 μM, respectively. Azinonone anti-tuberculosis drugs have high cLogP value and poor druggability

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Benzothiazinone derivative, preparation method thereof and application of benzothiazinone derivative as antituberculosis drug
  • Benzothiazinone derivative, preparation method thereof and application of benzothiazinone derivative as antituberculosis drug
  • Benzothiazinone derivative, preparation method thereof and application of benzothiazinone derivative as antituberculosis drug

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0027] The preparation method of benzothiazinone derivative of the present invention is as follows:

[0028] (1) Compound A5 is reacted with an amine compound to obtain a benzothiazinone derivative;

[0029] (2) Reducing the benzothiazinone derivative prepared in step (1) to obtain compound A7; compound A7 undergoes a substitution reaction to obtain a benzothiazinone derivative.

[0030] Further, compound A3 is chlorinated to obtain acid chloride A4; compound A4 is reacted with isothiocyanate to obtain compound A5; A4 to A6 are one-pot reactions.

[0031] Specifically, the preparation of each compound of the present invention can refer to the following schematic route:

[0032]

[0033] The chemical structural formula of the amine compound is as follows:

[0034]

[0035] Wherein, the definition of the substituent is the same as above.

[0036] More specifically, the above reaction pathway can be exemplified as follows:

[0037] The steps of A1→A3 are: compound A1 is...

Embodiment 1

[0042] Example 1 Compound 1: 2-(4-(cyclohexylmethyl)piperazin-1-yl)-6-(methylsulfonyl)-8-nitro-4 H -Benzo[ e ][1,3]thiazin-4-one

[0043]

[0044] Dissolve ammonium thiocyanate (46 mg, 1.2 eq.) in 5 mL of anhydrous acetone, add polyethylene glycol (0.05 eq., based on compound A3) dropwise, and stir until dissolved at room temperature to obtain isothiocyanate ammonium acid solution;

[0045] Compound A3 (50 mg, 1eq. , R 3 is methyl) dissolved in dichloromethane (anhydrous) (5 mL), dropwise N, N - Dimethylformamide (0.05eq., based on compound A3), add dropwise oxalyl chloride (0.25 mL, 2.5eq.), stir at room temperature for 0.5 hours after the addition is complete, spin dry the solvent and excess oxalyl chloride to obtain the corresponding intermediate acid chloride compound (compound A4, R 3 is methyl); then dropwise add the above-mentioned ammonium isothiocyanate solution, stir at room temperature for 20 minutes after the dropwise addition is completed, and the reactio...

Embodiment 2

[0047] Example 2 Compound 3: 2-(3-(methoxyimino)azetidin-1-yl)-6-(methylsulfonyl)-8-nitro-4 H -Benzo[ e ][1,3]thiazin-4-one

[0048]

[0049] The operation was the same as in Example 1, except that the amine used was azetidine-3-oxo-methyloxime, and the rest remained unchanged to obtain compound 3 as a white solid (yield 46%). 1 H NMR (400 MHz, DMSO-d 6 ) δ 9.34 (s, 1H), 9.08 (s, 1H), 5.05 – 5.04 (m, 4H), 3.93 (s, 3H), 3.19 (s, 3H). 13 C NMR (101 MHz, DMSO-d 6 ) δ 165.3, 162.0, 146.0, 144.1, 139.8, 135.6, 134.3, 128.3, 126.1, 62.5, 60.2, 43.52. MS-ESI (m / z): 384.6 [M+H] + .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a benzothiazinone derivative, a preparation method thereof and application of the benzothiazinone derivative as an antituberculosis drug, which relate to a novel compound witha benzothiazinone skeleton. The compound has an inhibition effect on tubercle bacillus, particularly tubercle bacillus with clinical drug resistance. The benzothiazinone skeleton benzene ring is creatively changed, especially the substituent group is creatively changed to obtain a series of compounds, and an unexpected technical effect is achieved; the compound disclosed by the invention has an excellent inhibition effect on tubercle bacillus; compared with the existing clinical first-line drug isoniazide (MIC 0.5 muM), the reported compound activity has very great advantages, and more importantly, compared with the benzothiazinone antituberculosis drug pBTZ 169 in the existing research stage, the compound provided by the invention has a lower cLogP value and better druggability.

Description

technical field [0001] The technical field of the present invention relates to the application of antibacterial drugs, mainly for the research and development of drugs for bacilli, such as Mycobacterium tuberculosis or Bacillus leprae, after infecting the human body; specifically, it relates to a new class of compounds with a benzothiazinone skeleton. It has been shown to have an inhibitory effect on Mycobacterium tuberculosis, especially it also has an inhibitory effect on Mycobacterium tuberculosis with clinical drug resistance. Background technique [0002] Tuberculosis is one of the infectious diseases and remains one of the leading causes of death in developing countries. There are many carriers of Mycobacterium tuberculosis, and one out of every three people is a carrier of Mycobacterium tuberculosis, that is, there are nearly 2 billion Mycobacterium tuberculosis carriers in the world. In addition, due to the slow growth and reproduction of tuberculosis, it usually ta...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D279/08C07D417/04C07D417/12C07D491/113C07D417/14C07D471/10A61K31/5415A61P31/06
CPCC07D279/08C07D417/04C07D417/12C07D491/113C07D417/14C07D471/10A61P31/06
Inventor 乔春华
Owner SUZHOU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com